SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)																	1 Months Ended					3 Months Ended					4 Months Ended	9 Months Ended		12 Months Ended
	Oct. 17, 2022 shares	Jul. 12, 2022 USD ($) shares	Jun. 10, 2022 USD ($)	Mar. 15, 2022 USD ($)	Feb. 03, 2022 USD ($) $ / shares shares	Jan. 27, 2022 shares	Sep. 08, 2021 USD ($) shares	Jun. 14, 2021 USD ($) shares	May 13, 2021 USD ($) shares	Apr. 12, 2021 USD ($) shares	Mar. 18, 2021 USD ($)	Mar. 12, 2021 USD ($) $ / shares shares	Feb. 26, 2021 USD ($) $ / shares	Oct. 15, 2020 USD ($) shares	Sep. 30, 2020 shares	Sep. 08, 2020 USD ($) shares	Sep. 30, 2022 USD ($) $ / shares	Jul. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Jun. 14, 2021 USD ($) shares	Sep. 30, 2022 USD ($) $ / shares	Sep. 30, 2022 USD ($) $ / shares	Jun. 30, 2022 USD ($) shares	Sep. 30, 2021 USD ($) shares	Jun. 30, 2021 USD ($) shares	Dec. 31, 2021 USD ($) $ / shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) $ / shares shares	Nov. 29, 2023 USD ($)	Sep. 30, 2022 AUD ($)	Jul. 14, 2022 USD ($)	Oct. 29, 2021 USD ($)	Jun. 10, 2021 USD ($)	May 31, 2021 shares	Apr. 20, 2021	Dec. 31, 2020 USD ($)	Mar. 02, 2020 USD ($)
Number of warrant purchased | shares																																				8,487,324
Common stock, par value | $ / shares																	$ 0.001					$ 0.001	$ 0.001				$ 0.001	$ 0.001		$ 0.001
Shares issued per share | $ / shares												$ 10.03
Beneficial conversion feature value												$ 50,770,192
Debt conversion instrument, shares issued | shares						10,000,000
Cash equivalents																	$ 0					$ 0	$ 0				$ 0	$ 0		$ 0
Restricted cash																	630,285					630,285	630,285		$ 4,996,543			630,285	$ 4,996,543
Account receivables																	171,380					171,380	171,380				39,622	171,380		39,622
Accounts receivable, net																	0					0	0				2,500	0		2,500
Accounts receivable, allowance of doubtful accounts																	0					0	0				0	0		0
Notes receivable, related parties																	2,674,074					2,674,074	2,674,074				12,792,671	2,674,074		12,792,671
Invested amount																	79,486,590					79,486,590	79,486,590				82,645,469	79,486,590		82,645,469
Gain on loss on investment																		$ 74,827
Investment at fair value																	30,176,538					30,176,538	30,176,538				35,327,987	30,176,538		35,327,987
Cost of investment																	98,129					98,129	98,129				99,216	$ 98,129		$ 99,216
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | shares
Number of shares issued, value																									33,889,304	$ 39,268,580
Additional paid in capital																	322,318,500					322,318,500	322,318,500				296,181,977	$ 322,318,500		$ 296,181,977
Unrealized loss on securities investment																												21,773,223	35,972,445
Investment in capital																	21,232,707					21,232,707	21,232,707					21,232,707
Convertible debt, fair value disclosures																											9,799			9,799
Payment of related parties																													840,000
Notes payable related parties																	0					0	0				0	0		0
Transaction loss																												(446,104)
Capitalized construction costs																						2,900,000			1,800,000			5,900,000	3,200,000
Payments for rent																												30,998,258
Stock-based compensation																						0			73,292			0	73,292
Foreign currency transaction gain loss																						132,092			578,903			2,617,896	1,842,128
Other comprehensive loss																						520,339			$ 1,238,356			3,729,724	$ 4,077,987
Non controlling interest																	12,015,513					12,015,513	12,015,513				21,912,268	12,015,513		21,912,268
Capitalized financing costs																	3,247,739					$ 3,247,739	$ 3,247,739				3,247,739	3,247,739		3,247,739
Subsequent Event [Member]
Shares issued for acquisition | shares	13,834,643
Private Placement [Member] | Sponsor [Member]
Issuance of shares of common stock | shares					473,750
Purchase price of private placement amount					$ 4,737,500
Alset Capital Acquisition Corp [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | shares					1,125,000
Alset Capital Acquisition Corp [Member]
Shares issued per share | $ / shares					$ 10.00
Shares issued for acquisition | shares					7,500,000
Gain on loss on investment																												$ 82,582
Number of shares issued, value																	$ 476,250
Additional paid in capital																			$ 2,830,961					2,830,961
Unrealized loss on securities investment																			237,578	$ 237,578
Ownership percentage																	100.00%					100.00%	100.00%					100.00%				100.00%
HWH World [Member]
Ownership percentage																	19.00%					19.00%	19.00%					19.00%				19.00%
Payment of related parties																												$ 187,500
HWH World Co [Member]
Ownership percentage																	51.00%					51.00%	51.00%					51.00%				51.00%
AMRE and AMRE Management [Member]
Ownership percentage																	80.80%					80.80%	80.80%					80.80%				80.80%
American Pacific Bancorp Inc [Member]
Invested amount																	$ 31,380,155					$ 31,380,155	$ 31,380,155				30,801,129	$ 31,380,155		30,801,129
Gain on loss on investment																						419,005					51,999	579,026
Cost of investment							$ 2,600,000
Deconsolidation description							As a result of the new share issuances, the Company’s ownership percentage of APB fell below 50% to 41.3% and the entity was deconsolidated in accordance with ASC 810-10. Upon deconsolidation the Company elected to apply the equity method accounting as the Company still retained significant influence. As a result of the deconsolidation, the Company recognized gain of approximately $28.2 million.
Gain on deconsolidation							$ 28,200,000
Equity method investement							30,800,000
Net assets							$ 2,900,000
American Medical REIT Inc [Member]
Loans and Leases Receivable, Related Parties																	200,000					200,000	200,000				200,000	$ 200,000		200,000
Ballenger Projects [Member]
Risk percentage																												18.00%	70.00%
Brokerage [Member]
Restricted cash																	321,140					321,140	321,140				304,570	$ 321,140		304,570
Novum Alpha Fund [Member]
Invested amount																			$ 100,000					$ 100,000
Sharing Services Convertible Note [Member]
Invested amount																	50,000					50,000	50,000					50,000
Debt instrument, face amount																																	$ 50,000
Iinterests receivable																																	$ 28,636
AUSTRALIA
Collateral deposit																																$ 50,000
Minimum [Member]
Payments for rent																												$ 2,300
Property, plant and equipment, useful life years																												10 years
Maximum [Member]
Payments for rent																												$ 23,020
Property, plant and equipment, useful life years																												27 years 6 months
Manufacturers and Traders Trust Company [Member]
Line of credit collateral				$ 2,300,000
Line of credit facility collateral outstanding				$ 300,000
Escrow Deposit																	309,145					309,145	309,145				4,399,984	$ 309,145		4,399,984
Manufacturers and Traders Trust Company [Member] | Minimum [Member]
Deposit securing the loan																	2,600,000					2,600,000	2,600,000					2,600,000
Common Stock [Member]
Issuance of shares of common stock | shares																								35,319,290	17,456,490	8,389,324
Number of shares issued, value																								$ 35,319	$ 17,457	$ 8,389
Common Stock [Member]
Purchase of stock | shares												4,775,523
Series A Common Stock [Member]
Purchase of stock | shares							6,666,700
Stock cost							$ 40,000,200
Common Class B [Member] | Private Placement [Member] | Sponsor [Member]
Issuance of shares of common stock | shares					2,156,250
Number of shares issued, value					$ 25,000
Alset CPN [Member]
Debt conversion instrument, amount								$ 63,920,128	$ 63,920,128
Accrued interest								$ 306,438	$ 306,438												$ 306,438
Debt conversion instrument, shares issued | shares								9,163,965	9,163,965
Alset CPN [Member] | Common Stock [Member]
Debt conversion instrument, shares issued | shares																					9,163,965
Alset CPN [Member] | Series B Preferred Stock [Member]
Debt conversion instrument, shares issued | shares								2,123	2,123												2,123
Value Exchange International [Member]
Shares issued for acquisition | shares										6,500,000
Cost of investment in securities at fair value										$ 650,000
American Medical REIT Inc [Member]
Warrants and rights outstanding																											0			0
Accrued interest																	$ 0					$ 0	0				130,000	0		130,000
Notes receivable, related parties																																		$ 200,000					$ 200,000
Fair value of warrants																												$ 0		0
Debt instrument, face amount																																		$ 8,350,000					$ 200,000
Debt instrument, interest percentage																																							8.00%
Notes payable related parties																				200,000
Unrealized loss on security investment																							$ 2,157,984
Vivacitas [Member]
Common stock, par value | $ / shares																	$ 1					$ 1	$ 1					$ 1
Number of shares purchased | shares																												250,000
Fair value of stock option																																						$ 0
Liquid Value Asset Management Limited [Member]
Loan lend																	$ 3,000,000					$ 3,000,000	$ 3,000,000					$ 3,000,000
Investment at fair value																	3,032,185					3,032,185	3,032,185				$ 2,987,039	3,032,185		$ 2,987,039
Document Securities Systems Inc [Member]
Gain on sale of investments											$ 2,480,000
Cost method investments, original cost											$ 2,279,872
Document Securities Systems Inc [Member] | Convertible Debt [Member]
Debt conversion instrument, shares issued | shares		21,366,177
SeD Capital Pte Ltd [Member] | Novum Alpha Pte Ltd [Member]
Joint venture																																					50.00%
SeD Capital Pte Ltd [Member] | Credas Capital Pte Ltd [Member]
Joint venture																																					50.00%
Ketomei Pte Ltd [Member]
Additional investment			$ 179,595
Vector Com co. Ltd [Member]
Invested amount													$ 88,599
Debt instrument, face amount																	$ 88,599					$ 88,599	$ 88,599					$ 88,599
Debt instrument, interest percentage													2.00%
Debt instrument, term													2 years
Debt instrument, convertible, conversion price | $ / shares													$ 21.26
Amarantus Bio Science Holdings [Member]
Ownership in fair value investment rate																	4.30%					4.30%	4.30%					4.30%				4.30%
Trust Partner [Member]
Ownership in fair value investment rate																											15.50%			15.50%
Value Exchange International [Member]
Ownership in fair value investment rate																	18.10%					18.10%	18.10%					18.10%				18.10%
Document Securities Systems Inc [Member]
Onwership percentage																	45.18%					45.18%	45.18%				24.90%	45.18%		24.90%		45.18%
Holista Coll Tech Limited [Member]
Ownership in fair value investment rate																	15.50%					15.50%	15.50%					15.50%				15.50%
American Premium Water Corp [Member]
Onwership percentage																	0.80%					0.80%	0.80%					0.80%				0.80%
American Medical REIT Inc [Member]
Onwership percentage																	15.80%					15.80%	15.80%					15.80%				15.80%
Nervotec Pte Ltd [Member]
Shares issued for acquisition | shares																1,666
Ownership in investment at cost																1.45%
Cost of stock																$ 37,826
Hyten Global Thailand Co Ltd [Member]
Shares issued for acquisition | shares															3,800
Ownership in investment at cost															19.00%
Cost of stock																												$ 42,562
K Beauty Research Lab Co Ltd [Member]
Onwership percentage																											18.00%			18.00%
Cost of investment																											$ 19,609			$ 19,609
Alset Capital Acquisition Crop [Member]
Onwership percentage																	23.40%					23.40%	23.40%					23.40%				23.40%
Debt instrument, face amount																	$ 0					$ 0	$ 0					$ 0
Alset Capital Acquisition Crop [Member] | Chief Executive Officer [Member]
Onwership percentage					23.40%
Sponsor [Member]
Onwership percentage																	10.00%					10.00%	10.00%					10.00%				10.00%
Ketomei Pte Ltd [Member]
Onwership percentage			28.00%
Invested amount																	$ 217,321					$ 217,321	$ 217,321					$ 217,321
Gain on loss on investment																						5,937						38,996
Amount lent																																			$ 76,723
American Medical REIT Inc [Member]
Receivables net																	0					0	0				$ 8,901,285	0		$ 8,901,285
Transaction loss		$ 1,089,675
Unrealized loss on security investment																							2,157,984
American Medical REIT Inc [Member] | Subsequent Event [Member]
Loans and Leases Receivable, Related Parties																															$ 8,350,000
American Medical REIT Inc [Member] | Loan One [Member]
Onwership percentage																											3.40%			3.40%
Debt instrument, interest percentage																											8.00%			8.00%
Loans and Leases Receivable, Related Parties		$ 8,350,000																									$ 8,350,000			$ 8,350,000
Notes payable related parties																				$ 200,000
AMRE and AMRE Management [Member]
Onwership percentage																				15.80%
Liquid Value Development Pte Ltd [Member]
Stock repurchased during period, value												$ 173,395
American Pacific Bancorp [Member]
Shares issued for acquisition | shares														250,000
American Pacific Bancorp [Member] | Hengfeng Finance Limited [Member]
Shares issued for acquisition | shares														3,500,001
Onwership percentage														100.00%
Purchase price														$ 1,500,000
Variable Interest Entity, Primary Beneficiary [Member]
Receivables net																	$ 236,699					236,699	$ 236,699				236,699	236,699		236,699
Securities Purchase Agreement [Member]
Accounts payable, current												$ 63,920,129
Common stock, par value | $ / shares												$ 0.001
Shares issued per share | $ / shares												$ 5.59
Securities Purchase Agreement [Member] | Alset International Limited [Member]
Number of warrant purchased | shares												1,500,000,000
Warrants and rights outstanding												$ 28,363,966
Securities Purchase Agreement [Member] | Liquid Value Development Pte Ltd [Member]
Stock repurchased during period, value												173,395
Securities Purchase Agreement [Member] | True Partner Capital Holding Limited [Member]
Stock repurchased during period, value												$ 6,729,629
Stock repurchased during period, shares | shares												62,122,908
Securities Purchase Agreement [Member] | American Pacific Bancorp Inc [Member]
Stock repurchased during period, value												$ 28,653,138
Stock repurchased during period, shares | shares												4,775,523
Loan Agreement [Member] | National Australian Bank Limited [Member]
Collateral deposit																											$ 36,316			36,316
Front Foot Benefit Assessments [Member]
Deferred revenue																						$ 9,968			$ 182,813			126,055	$ 431,458
Front Foot Benefit Assessments [Member] | Minimum [Member]
Proceeds from sale of property, plant, and equipment																												3,000
Front Foot Benefit Assessments [Member] | Maximum [Member]
Proceeds from sale of property, plant, and equipment																												4,500
Deferred Revenue [Member]
Deferred revenue																												$ 65,091		$ 728,343